Fulcrum Therapeutics, Inc. (FULC)
3.76
-0.01
(-0.27%)
USD |
NASDAQ |
Sep 18, 16:00
3.765
0.00 (0.00%)
After-Hours: 20:00
Fulcrum Therapeutics Total Long Term Debt (Quarterly) : 2.76M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.76M |
| March 31, 2026 | 3.406M |
| December 31, 2025 | 4.039M |
| September 30, 2025 | 4.663M |
| June 30, 2025 | 5.278M |
| March 31, 2025 | 5.866M |
| December 31, 2024 | 6.443M |
| September 30, 2024 | 7.011M |
| June 30, 2024 | 7.57M |
| March 31, 2024 | 8.105M |
| December 31, 2023 | 8.629M |
| September 30, 2023 | 9.145M |
| June 30, 2023 | 9.653M |
| March 31, 2023 | 10.14M |
| December 31, 2022 | 10.82M |
| September 30, 2022 | 11.50M |
| June 30, 2022 | 12.16M |
| Date | Value |
|---|---|
| March 31, 2022 | 12.80M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.004M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.03M |
| June 30, 2020 | 0.043M |
| March 31, 2020 | 0.051M |
| December 31, 2019 | 0.071M |
| September 30, 2019 | 0.049M |
| June 30, 2019 | 165.18M |
| March 31, 2019 | 165.18M |
| December 31, 2018 | 139.79M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 0.989M |
| CNBX Pharmaceuticals, Inc. | 0.00 |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 6.30M |
| Definium Therapeutics, Inc. | 36.47M |